Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Sep 09 2020

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Release

Cadila Healthcare Limited has informed the Exchange regarding a press release dated September 09, 2020, titled "Zydus Cadila receives tentative approval from USFDA for Empagliflozin and Linagliptin Tablets".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases